Annual ROE
113.05%
-579.95%-83.69%
31 December 2023
Summary:
Seelos Therapeutics annual return on equity is currently 113.05%, with the most recent change of -579.95% (-83.69%) on 31 December 2023. During the last 3 years, it has risen by +855.70% (+115.22%). SEEL annual ROE is now -99.98% below its all-time high of 732.21 thousand%, reached on 31 December 2019.SEEL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-13.07%
-88.28%-117.38%
30 June 2024
Summary:
Seelos Therapeutics quarterly return on equity is currently -13.07%, with the most recent change of -88.28% (-117.38%) on 30 June 2024. Over the past year, it has dropped by -200.78% (-106.96%). SEEL quarterly ROE is now -102.84% below its all-time high of 460.18%, reached on 30 June 2023.SEEL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.7% | -107.0% |
| 3 y3 years | +115.2% | +86.8% |
| 5 y5 years | +131.5% | +98.6% |
SEEL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.7% | +115.2% | -102.8% | +99.9% |
| 5 y | 5 years | -100.0% | +115.2% | -102.8% | +99.9% |
| alltime | all time | -100.0% | +107.5% | -102.8% | +99.9% |
Seelos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -13.07%(-117.4%) |
| Mar 2024 | - | 75.21%(-34.6%) |
| Dec 2023 | 113.05%(-83.7%) | 115.00%(-38.7%) |
| Sept 2023 | - | 187.71%(-59.2%) |
| June 2023 | - | 460.18%(-104.5%) |
| Mar 2023 | - | -10.29 K%(+2317.9%) |
| Dec 2022 | 693.00%(-701.5%) | -425.47%(+77.5%) |
| Sept 2022 | - | -239.70%(+65.1%) |
| June 2022 | - | -145.17%(+54.0%) |
| Mar 2022 | - | -94.26%(-15.2%) |
| Dec 2021 | -115.22%(-84.5%) | -111.15%(+12.4%) |
| Sept 2021 | - | -98.91%(-25.1%) |
| June 2021 | - | -131.99%(-62.7%) |
| Mar 2021 | - | -353.93%(-8.6%) |
| Dec 2020 | -742.65%(-100.1%) | -387.13%(-28.8%) |
| Sept 2020 | - | -543.45%(+26.0%) |
| June 2020 | - | -431.29%(+15.5%) |
| Mar 2020 | - | -373.33%(-66.6%) |
| Dec 2019 | 732.21 K%(<-9900.0%) | -1119.29%(+22.9%) |
| Sept 2019 | - | -910.85%(-26.6%) |
| June 2019 | - | -1240.27%(+1.4%) |
| Mar 2019 | - | -1222.79%(+293.4%) |
| Dec 2018 | -359.33%(-4995.5%) | -310.81%(+73.4%) |
| Sept 2018 | - | -179.24%(-16.1%) |
| June 2018 | - | -213.72%(+14.9%) |
| Mar 2018 | - | -186.04%(-2724.0%) |
| Dec 2017 | 7.34%(-92.6%) | 7.09%(-95.5%) |
| Sept 2017 | - | 158.79%(-160.5%) |
| June 2017 | - | -262.29%(+393.1%) |
| Mar 2017 | - | -53.19%(-156.1%) |
| Dec 2016 | 98.90%(-48.3%) | 94.88%(-15.4%) |
| Sept 2016 | - | 112.14%(-27.5%) |
| June 2016 | - | 154.77%(-28.5%) |
| Mar 2016 | - | 216.34%(-44.7%) |
| Dec 2015 | 191.30%(-156.6%) | 391.52%(-110.2%) |
| Sept 2015 | - | -3840.30%(+479.4%) |
| June 2015 | - | -662.85%(+93.1%) |
| Mar 2015 | - | -343.26%(+43.8%) |
| Dec 2014 | -338.00%(+75.5%) | -238.76%(+354.8%) |
| Sept 2014 | - | -52.50%(+4.8%) |
| June 2014 | - | -50.09%(-61.2%) |
| Mar 2014 | - | -129.25%(-35.4%) |
| Dec 2013 | -192.55%(-65.3%) | -200.10%(-37.6%) |
| Sept 2013 | - | -320.92%(+10.5%) |
| June 2013 | - | -290.55%(+8.3%) |
| Mar 2013 | - | -268.38%(+21.6%) |
| Dec 2012 | -555.49%(+151.2%) | -220.65%(+87.9%) |
| Sept 2012 | - | -117.41%(-23.8%) |
| June 2012 | - | -154.18%(-22.3%) |
| Mar 2012 | - | -198.38%(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -221.14%(-46.5%) | -224.58%(-15.8%) |
| Sept 2011 | - | -266.61%(+19.8%) |
| June 2011 | - | -222.51%(+14.2%) |
| Mar 2011 | - | -194.79%(-32.2%) |
| Dec 2010 | -413.50%(-72.7%) | -287.13%(-48.5%) |
| Sept 2010 | - | -557.69%(-29.4%) |
| June 2010 | - | -789.43%(-48.0%) |
| Mar 2010 | - | -1517.52%(-4.1%) |
| Dec 2009 | -1512.32%(+826.6%) | -1583.09%(+2918.9%) |
| Sept 2009 | - | -52.44%(-65.6%) |
| June 2009 | - | -152.53%(+12.2%) |
| Mar 2009 | - | -135.92%(-33.1%) |
| Dec 2008 | -163.21%(+51.5%) | -203.29%(-20.0%) |
| Sept 2008 | - | -253.99%(+64.1%) |
| June 2008 | - | -154.74%(+22.4%) |
| Mar 2008 | - | -126.41%(+18.5%) |
| Dec 2007 | -107.76%(-18.6%) | -106.68%(+5.6%) |
| Sept 2007 | - | -101.00%(-0.3%) |
| June 2007 | - | -101.26%(+8.3%) |
| Mar 2007 | - | -93.46%(-32.5%) |
| Dec 2006 | -132.46%(-48.4%) | -138.45%(-37.6%) |
| Sept 2006 | - | -221.77%(-15.0%) |
| June 2006 | - | -260.82%(-21.6%) |
| Mar 2006 | - | -332.89%(+9.9%) |
| Dec 2005 | -256.48%(+81.7%) | -302.93%(+22.8%) |
| Sept 2005 | - | -246.59%(+17.4%) |
| June 2005 | - | -210.11%(+14.7%) |
| Mar 2005 | - | -183.15%(+16.5%) |
| Dec 2004 | -141.13%(-34.7%) | -157.19%(-4.6%) |
| Sept 2004 | - | -164.77%(+7.2%) |
| June 2004 | - | -153.74%(-16.4%) |
| Mar 2004 | - | -183.85%(-9.1%) |
| Dec 2003 | -216.14%(+6.9%) | -202.23%(-11.6%) |
| Sept 2003 | - | -228.73%(-13.3%) |
| June 2003 | - | -263.89%(+10.6%) |
| Mar 2003 | - | -238.57%(+29.0%) |
| Dec 2002 | -202.27%(+293.0%) | -184.92%(+48.3%) |
| Sept 2002 | - | -124.73%(+40.3%) |
| June 2002 | - | -88.89%(+36.1%) |
| Mar 2002 | - | -65.29%(+30.9%) |
| Dec 2001 | -51.47%(+33.0%) | -49.86%(+32.3%) |
| Sept 2001 | - | -37.70%(+6.3%) |
| June 2001 | - | -35.47%(-3.5%) |
| Mar 2001 | - | -36.76%(+15.1%) |
| Dec 2000 | -38.69%(-65.2%) | -31.94%(+37.8%) |
| Sept 2000 | - | -23.18%(-5.2%) |
| June 2000 | - | -24.44%(+135.0%) |
| Mar 2000 | - | -10.40% |
| Dec 1999 | -111.18%(-155.6%) | - |
| Dec 1998 | 199.92%(-52.0%) | - |
| Dec 1997 | 416.44% | - |
FAQ
- What is Seelos Therapeutics annual return on equity?
- What is the all time high annual ROE for Seelos Therapeutics?
- What is Seelos Therapeutics annual ROE year-on-year change?
- What is Seelos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly ROE year-on-year change?
What is Seelos Therapeutics annual return on equity?
The current annual ROE of SEEL is 113.05%
What is the all time high annual ROE for Seelos Therapeutics?
Seelos Therapeutics all-time high annual return on equity is 732.21 K%
What is Seelos Therapeutics annual ROE year-on-year change?
Over the past year, SEEL annual return on equity has changed by -579.95% (-83.69%)
What is Seelos Therapeutics quarterly return on equity?
The current quarterly ROE of SEEL is -13.07%
What is the all time high quarterly ROE for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly return on equity is 460.18%
What is Seelos Therapeutics quarterly ROE year-on-year change?
Over the past year, SEEL quarterly return on equity has changed by -200.78% (-106.96%)